Alira Health Welcomes Richard Charter, Vice President, Market Access, MedTech, Europe & Asia-Pacific
BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, welcomes Richard Charter as Vice President, Market Access, MedTech, Europe & Asia-Pacific to our office in Basel, Switzerland. Richard brings extensive experience in the MedTech industry and a comprehensive background in both financial and health economics to our Market Access Team.
“At Alira Health, our aim is to become the number one market access MedTech player in the EU and U.S. by 2023. Richard’s vast experience and ability to create value for our customers and partners will help us to reach this goal and strengthen our commitment to a segment that is often overlooked for its size and complexity,” said Jean-François Ricci, Executive Vice President, Global Market Access, Alira Health. “Richard will lead Alira Health’s experienced MedTech Market Access Team in the EU, pioneer new MedTech specific methodologies and tools, and drive partnerships with the most important associations and academic institutions in the world to enable healthcare transformation for our MedTech clients.”
“I am thrilled to join Alira Health’s senior leadership and join Jean-François and the Global Market Access Team in Basel, Switzerland,” said Richard. “This represents a fantastic opportunity to take Alira Health’s existing medical technology capabilities in product development, clinical trial development, and regulatory affairs, and further expand our MedTech market access capabilities. These capabilities are critical for successful product launch and payer/provider engagement. This team can deliver unparalleled solutions for our clients and lead MedTech Market Access globally.”
Richard brings over 15 years of experience in financial and health economics across multiple sectors, including financial services and healthcare. Richard has focused exclusively on the MedTech market access space, including leading the market access and pricing functions at a major medical device company.
Currently, Richard is the Co-chair of the ISPOR Medical Device Special Interest Group and Co-chair of the HTAi Medical Device Interest Group, the industry advisor to the EU-funded Horizon 2020 COMED initiative on cost and outcomes measurement for medical devices (COMED). Previously, Richard was the Chairperson of the MedTech Europe Evidence & Payers Working Group and core contributor to the Value-Based Procurement Working Group.